EUDA Health stock gained 12.08 percent after Q2 results

Published on 10/07/2026 at 01:07 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

EUDA Health stock reported six-month revenue of USD 3,467,835 through June 30, 2026. Net loss narrowed to USD 796,950 as cash stood at USD 365,904.

EUDA, VGG3142E1473, Illustration mit AI erstellt.

EUDA Health stock (ISIN VGG3142E1473) was last at USD 19.39 on Nasdaq on October 6, 2026 at 4:00 p.m. ET, up 12.08 percent. The move followed the company's reported six-month results for the period ended June 30, 2026, filed on September 29, 2026, according to StockTitan.

Revenue improves in six months

EUDA reported revenue of USD 3,467,835 for the six months ended June 30, 2026, compared with USD 3,057,323 in the same 2025 period. That represents a 13.4 percent increase, although the absolute revenue base remains small for a Nasdaq-listed company.

Property management services generated USD 2,255,161, while holistic wellness consumer products and services contributed USD 1,212,674 in the same six-month period. The filing also showed that the company operates through property management and wellness activities after streamlining its earlier medical services operations.

Loss narrows but cash remains tight

Net loss narrowed to USD 796,950 from USD 1,201,696 in the prior-year period, a 33.7 percent improvement. The filing gave the comparison and period, while MarketBeat reported adjusted quarter-level context of USD 1.73 million in revenue and a USD 0.17 loss per share for Q2 2026.

Operating cash flow was negative at USD 1,206,041 for the six months ended June 30, 2026, compared with USD 1,215,423 of cash used in the same 2025 period. Cash and cash equivalents stood at USD 365,904 at June 30, while the filing said management had identified substantial doubt about the company's ability to continue as a going concern within one year after the financial statements were issued.

EUDA Health stock gains 12.08 percent

EUDA Health stock traded between USD 17.11 and USD 19.77 on October 6, 2026, with volume of 13,402 shares. The USD 19.39 last price was 77.4 percent above the 52-week low of USD 5.26 and 77.5 percent below the 52-week high of USD 86.00.

The market capitalization was USD 36.2 million as of October 6, 2026. For investors, the key tension is visible in the numbers: revenue increased 13.4 percent year over year, but operating cash use remained above USD 1.2 million for the first half of 2026.